ELI LILLY & CO (LLY)
Clinical trial NCT03363464 updates: 1. completion date: 2026-05-31 → 2026-06-30 2. primary completion date: 2026-05-31 → 2026-06-30
Clinical trial NCT03363464 updates: 1. completion date: 2026-05-31 → 2026-06-30 2. primary completion date: 2026-05-31 → 2026-06-30
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical